Concepedia
8
Publications
632
Citations
H-Index
2007
Active since
Affiliations
University College London(Current)
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (United States)
Peter Lundh von Leithner is an author at University College London specializing in vascular biology, medicine, and physiology.
Top concepts
GlaucomaMedicinePhysiologyOphthalmologyVascular BiologyComplement System
Publications per year
2007–2018
Targeting key angiogenic pathways with a bispecific Cross <scp>MA</scp> b optimized for neovascular eye diseases
Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton et al. · EMBO Molecular Medicine · 2016 · 333 citations · Full text
Assessing a Novel Depot Delivery Strategy for Noninvasive Administration of VEGF/PDGF RTK Inhibitors for Ocular Neovascular Disease
Scott Robbie, Peter Lundh von Leithner, Meihua Ju et al. · Investigative Ophthalmology & Visual Science · 2013 · 74 citations
Assessment of Rat and Mouse RGC Apoptosis Imaging<i>in Vivo</i>with Different Scanning Laser Ophthalmoscopes
Peter Lundh von Leithner, Vy Luong, Li Guo et al. · Current Eye Research · 2007 · 62 citations · Full text
Complement Factor H Is Critical in the Maintenance of Retinal Perfusion
Peter Lundh von Leithner, Jaimie Hoh Kam, James Bainbridge et al. · American Journal Of Pathology · 2009 · 50 citations · Full text
Complement System, Ocular Disease, Retina +7
BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes
Vivian K. Lee, Brett Hosking, Joanna Holeniewska et al. · Diabetologia · 2018 · 47 citations · Full text
Rows per page
1–5 of 8